Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria.

Over the past decade, reactive nitrogen intermediates joined reactive oxygen intermediates as a biochemically parallel and functionally non-redundant pathway for mammalian host resistance to many microbial pathogens. The past year has brought a new appreciation that these two pathways are partially redundant, such that each can compensate in part for the absence of the other. In combination, their importance to defense of the murine host is greater than previously appreciated. In addition to direct microbicidal actions, reactive nitrogen intermediates have immunoregulatory effects relevant to the control of infection. Genes have been characterized in Mycobacterium tuberculosis and Salmonella typhimurium that may regulate the ability of pathogens to resist reactive nitrogen and oxygen intermediates produced by activated macrophages.

[1]  B. Brüne,et al.  Nitric oxide and its role in apoptosis. , 1998, European journal of pharmacology.

[2]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[3]  D. Kwiatkowski,et al.  1,25-Dihydroxyvitamin D3 Induces Nitric Oxide Synthase and Suppresses Growth of Mycobacterium tuberculosis in a Human Macrophage-Like Cell Line , 1998, Infection and Immunity.

[4]  C. Nathan,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .

[5]  D. Goldberg,et al.  Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. , 1998, The Journal of biological chemistry.

[6]  N. Boéchat,et al.  Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis , 1996, The Journal of experimental medicine.

[7]  N. Hibler,et al.  Response to Reactive Nitrogen Intermediates inMycobacterium tuberculosis: Induction of the 16-Kilodalton α-Crystallin Homolog by Exposure to Nitric Oxide Donors , 1999, Infection and Immunity.

[8]  H. Whittle,et al.  Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. , 1999, The Journal of infectious diseases.

[9]  F. Fang,et al.  The transcriptional regulator SoxS is required for resistance of Salmonella typhimurium to paraquat but not for virulence in mice , 1997, Infection and immunity.

[10]  F. Fang,et al.  Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Casanova,et al.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.

[12]  A. Fischer,et al.  Incidence, severity, and prevention of infections in chronic granulomatous disease. , 1989, The Journal of pediatrics.

[13]  R. M. Simpson,et al.  The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[15]  E. N. Miller,et al.  Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[16]  B. Hamilton,et al.  Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  M. P. Gallagher,et al.  The Salmonella typhimurium AhpC Polypeptide Is Not Essential for Virulence in BALB/c Mice but Is Recognized as an Antigen during Infection , 1998, Infection and Immunity.

[18]  A. Zychlinsky,et al.  The induction of apoptosis by bacterial pathogens. , 1999, Annual review of microbiology.

[19]  Alfred Hausladen,et al.  Nitrosative Stress: Activation of the Transcription Factor OxyR , 1996, Cell.

[20]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[21]  K. Chung,et al.  Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages , 2002 .

[22]  C. Bogdan,et al.  Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .

[23]  P. Holt,et al.  Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. , 1998, Journal of immunology.

[24]  S. Tannenbaum,et al.  Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages , 1995, Infection and immunity.

[25]  B. Light,et al.  Mycobacteriocidal Action of Exogenous Nitric Oxide , 1999, Antimicrobial Agents and Chemotherapy.

[26]  V. Stewart,et al.  Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12 , 1996, Journal of bacteriology.

[27]  E. Clementi,et al.  Generation of Nitric Oxide by the Inducible Nitric Oxide Synthase Protects γδ T Cells from Mycobacterium tuberculosis-Induced Apoptosis , 1999, The Journal of Immunology.

[28]  S. L. Chiang,et al.  In vivo genetic analysis of bacterial virulence. , 1999, Annual review of microbiology.

[29]  S. Cole,et al.  Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis , 1997, Infection and immunity.

[30]  S. Dorman,et al.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.

[31]  C. Nathan,et al.  noxR3, a Novel Gene fromMycobacterium tuberculosis, Protects Salmonella typhimurium from Nitrosative and Oxidative Stress , 1999, Infection and Immunity.

[32]  G. Storz,et al.  Activation of the OxyR transcription factor by reversible disulfide bond formation. , 1998, Science.

[33]  R. Döffinger,et al.  Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. , 1998, The Journal of clinical investigation.

[34]  D. Malo,et al.  Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg , 1993, Cell.

[35]  O. Kwon The role of nitric oxide in the immune response of tuberculosis. , 1997, Journal of Korean medical science.

[36]  F. Fang,et al.  Glucose 6-Phosphate Dehydrogenase Is Required forSalmonella typhimurium Virulence and Resistance to Reactive Oxygen and Nitrogen Intermediates , 1999, Infection and Immunity.

[37]  Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. , 1998 .

[38]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[39]  Simon Paul,et al.  Mycobacterium tuberculosis Catalase and Peroxidase Activities and Resistance to Oxidative Killing in Human Monocytes In Vitro , 1999, Infection and Immunity.

[40]  F. Heffron,et al.  Recombination‐deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages , 1993, Molecular microbiology.

[41]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[43]  L. Bossi,et al.  Inducible prophages contribute to Salmonella virulence in mice , 1999, Molecular microbiology.

[44]  S. Dorman,et al.  A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.

[45]  I. Charles,et al.  Inducible nitric oxide synthase polymorphism and fatal cerebral malaria , 1998, The Lancet.

[46]  P. Gros,et al.  Natural Resistance to Infection with Intracellular Pathogens: The Nramp1 Protein Is Recruited to the Membrane of the Phagosome , 1997, The Journal of experimental medicine.

[47]  S Falkow,et al.  The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Clifton E. Barry,et al.  Compensatory ahpC Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis , 1996, Science.

[49]  C. Nathan,et al.  Antimicrobial mechanisms of macrophages , 1992 .

[50]  T. Eisenstein,et al.  In Vivo Blockage of Nitric Oxide with Aminoguanidine Inhibits Immunosuppression Induced by an Attenuated Strain of Salmonella typhimurium, PotentiatesSalmonella Infection, and Inhibits Macrophage and Polymorphonuclear Leukocyte Influx into the Spleen , 1999, Infection and Immunity.

[51]  A. Hausladen,et al.  Nitrosative stress: metabolic pathway involving the flavohemoglobin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Zwilling,et al.  Role of Iron in Nramp1-Mediated Inhibition of Mycobacterial Growth , 1999, Infection and Immunity.

[53]  A. Peitzman,et al.  Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.

[54]  H. Whittle,et al.  Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.

[55]  J. Foster,et al.  Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Dinauer,et al.  Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. , 1999, Immunity.

[57]  G. Feng,et al.  Nitric oxide regulates Th1 cell development through the inhibition of IL‐12 synthesis by macrophages , 1998, European journal of immunology.

[58]  F. Fang Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[59]  T. Eisenstein,et al.  Salmonella typhimurium Infection in Mice Induces Nitric Oxide-Mediated Immunosuppression through a Natural Killer Cell-Dependent Pathway , 1998, Infection and Immunity.

[60]  C. Nathan,et al.  A Novel Antioxidant Gene from Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[61]  E. Medina,et al.  How important is Nramp1 in tuberculosis? , 1998, Trends in microbiology.

[62]  Lei Chen,et al.  Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. , 1998, Molecular cell.

[63]  M. Dinauer,et al.  Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[64]  M. Pallen,et al.  Bacterial copper‐ and zinc‐cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis , 1997, Molecular microbiology.

[65]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[66]  T. Billiar,et al.  Nitric Oxide Prevents IL-1β and IFN-γ-Inducing Factor (IL-18) Release from Macrophages by Inhibiting Caspase-1 (IL-1β-Converting Enzyme) , 1998, The Journal of Immunology.

[67]  F. Fang,et al.  DNA repair is more important than catalase for Salmonella virulence in mice. , 1995, The Journal of clinical investigation.

[68]  C. Bogdan,et al.  Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. , 1999, Science.

[69]  S. Gordon Phagocytosis : the host , 1999 .

[70]  M. Rajandream,et al.  Regulation of hmp Gene Transcription inMycobacterium tuberculosis: Effects of Oxygen Limitation and Nitrosative and Oxidative Stress , 1999, Journal of bacteriology.

[71]  N. Andrews,et al.  Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.

[72]  D. Goldberg,et al.  Role for the Salmonella Flavohemoglobin in Protection from Nitric Oxide* , 1998, The Journal of Biological Chemistry.

[73]  S. Grinstein,et al.  Host Resistance to Intracellular Infection: Mutation of Natural Resistance-associated Macrophage Protein 1 (Nramp1) Impairs Phagosomal Acidification , 1998, The Journal of experimental medicine.

[74]  Weinberg Jb Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. , 1998 .

[75]  B. Lell,et al.  Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria , 1998, The Lancet.

[76]  G. Church,et al.  Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[77]  S. Ichiyama,et al.  Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages , 1997, Infection and immunity.